Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | LMNA | P02545 | 2/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11956764 | 0.95 | CYP3A4 (0.37) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL15708348 | 0.90 | CYP3A4 (0.42) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL15726604 | 0.86 | KMT2A (0.44) | CYP3A4TSHRLMNATDP1KMT2A | |
| SCHEMBL15726608 | 0.86 | KMT2A (0.36) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL16270525 | 0.85 | GAA (0.39) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL15726640 | 0.85 | KMT2A (0.38) | CYP3A4TSHRGAALMNAKMT2A | |
| SCHEMBL2577691 | 0.84 | CYP3A4 (0.44) | CYP3A4TSHRGAALMNATDP1 | |
| SCHEMBL11956787 | 0.83 | PRSS1 (0.34) | CYP3A4TSHRLMNATDP1KMT2A | |
| SCHEMBL16573656 | 0.82 | SERPINE1 (0.35) | CYP3A4TSHRLMNATDP1KMT2A | |
| SCHEMBL15908149 | 0.81 | CYP1A2 (0.37) | CYP3A4TSHRGAATDP1HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140142199-A1 | ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES | BEZWADA BIOMEDICAL, LLC | 2014-05-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140142199-A1 | ABSORBABLE BRANCHED POLYESTERS AND POLYURETHANES | SI, MGAM, BPHL | CYP3A4 78/4885TSHR 4412/4885GAA 276/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.